Perhexiline

CHEMBL75880 Phase 4 Disetujui Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

277.5 g/mol

LogP

6.8

Phase

4

An antianginal drug used in some countries (particularly Australia) to treat refractory angina by shifting cardiac metabolism from fatty acids to glucose, reducing oxygen demand of the heart muscle. It requires therapeutic drug monitoring due to its variable metabolism and potential for liver and peripheral nerve toxicity.

Berat Molekul

277,5000 g/mol

LogP

6,80

TPSA

12,00 Å²

Lipinski RO5

Lulus

Area Terapeutik

Heart Failure

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Struktur 2D

SVG PNG

Cite this structure

Embed this structure

SMILES

C1CCC(C(CC2CCCCN2)C2CCCCC2)CC1

InChI

InChI=1S/C19H35N/c1-3-9-16(10-4-1)19(17-11-5-2-6-12-17)15-18-13-7-8-14-20-18/h16-20H,1-15H2

Molecular Formula

C19H35N

HBD / HBA

1 / 1

Ikatan yang Dapat Dirotasi

4

Atom Berat

20

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Pertanyaan yang Sering Diajukan

An antianginal drug used in some countries (particularly Australia) to treat refractory angina by shifting cardiac metabolism from fatty acids to glucose, reducing oxygen demand of the heart muscle. It requires therapeutic drug monitoring due to its variable metabolism and potential for liver and peripheral nerve toxicity.

Yes, Perhexiline is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL75880. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 4746. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

PillFYI

Mencari informasi yang ramah bagi pasien?

Perhexiline di PillFYI

Struktur

Data Cepat

Rumus: C19H35N

Tautan Eksternal

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

Penyangkalan Medis

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.